Published Date: 02 Mar 2023
New research has identified hundreds of proteins that can lead to the development of metabolic diseases, such as type 2 diabetes mellitus, and therefore have treatment potential.
Read Full NewsNew data show growing adoption of guidance to skip sentinel lymph node biopsy in older women with early breast cancer, though uptake remains slow and incomplete in the US.
Some studies have suggested that morning is the optimal time for immunotherapy, but a new analysis of patients with lung cancer begs to differ.
1.
When BCG is not effective in treating bladder cancer, Oncolytic Virus exhibits high response rates.
2.
For the treatment of vestibular schwannomas in neurofibromatosis type 2, stereotactic radiosurgery has been found to be effective.
3.
Glioblastoma treatment breakthrough shows promise
4.
Even after a partial ban, asbestos is still used and is a deadly carcinogen, according to the EPA.
5.
FDA Approves New Drug Combo for RR Multiple Myeloma
1.
A New Hope: How Procarbazine is Revolutionizing Cancer Treatment
2.
The Latest Research on Chronic Granulomatous Disease and Promising New Treatments
3.
Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments
4.
Understanding Sickle Cell Anemia: Causes, Symptoms, and Treatment Options
5.
Unlocking the Potential of Talquetamab: A Revolutionary Approach to Cancer Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation